|
Volumn 19, Issue 2, 2004, Pages 238-240
|
Cerebrospinal fluid Aβ42 levels in multiple system atrophy (multiple letters) [2]
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AMYLOID BETA PROTEIN[1-42];
AMYLOID BETA PROTEIN;
PEPTIDE FRAGMENT;
ADULT;
AGE;
AGED;
ALZHEIMER DISEASE;
ANAMNESIS;
CEREBROSPINAL FLUID ANALYSIS;
CEREBROSPINAL FLUID LEVEL;
CLINICAL OBSERVATION;
CONCENTRATION (PARAMETERS);
CONTROLLED STUDY;
DIAGNOSTIC VALUE;
DIFFERENTIAL DIAGNOSIS;
DISEASE COURSE;
DISEASE DURATION;
FEMALE;
HUMAN;
LABORATORY TEST;
LETTER;
LUMBAR PUNCTURE;
MAJOR CLINICAL STUDY;
MALE;
MEDICAL ASSESSMENT;
MEDICAL SPECIALIST;
METHODOLOGY;
NEUROLOGIC EXAMINATION;
PARKINSON DISEASE;
PATHOPHYSIOLOGY;
PATIENT SELECTION;
PRIORITY JOURNAL;
PROGNOSIS;
PROGRESSIVE SUPRANUCLEAR PALSY;
PROTEIN ANALYSIS;
SHY DRAGER SYNDROME;
CEREBROSPINAL FLUID;
MIDDLE AGED;
NOTE;
REFERENCE VALUE;
AGED;
AMYLOID BETA-PROTEIN;
DIAGNOSIS, DIFFERENTIAL;
FEMALE;
HUMANS;
MALE;
MIDDLE AGED;
MULTIPLE SYSTEM ATROPHY;
NEUROLOGIC EXAMINATION;
PARKINSON DISEASE;
PEPTIDE FRAGMENTS;
REFERENCE VALUES;
SUPRANUCLEAR PALSY, PROGRESSIVE;
|
EID: 1542300896
PISSN: 08853185
EISSN: None
Source Type: Journal
DOI: 10.1002/mds.10687 Document Type: Letter |
Times cited : (19)
|
References (0)
|